• Cauda equina syndrome
  • Human Growth Hormone (Somatotropin)
  • Insulin-Like Growth Factor I (IGF1)
  • Hydrocodone and Metabolites, Urine
  • Ceruloplasmin, Serum
  • Gonadotropin Releasing Hormone (Luteinizing releasing factor)
  • Hydromorphone, Urine
  • Low Density Lipoprotein (LDL, VLDL)
  • Cytomegalovirus (CMV) CD8 T-Cell Immune Competence, Quantitative Assessment by Flow Cytometry
  • MGMT (O-6-methylguanine-DNA methyltransferase) Methylation Detection
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Pain Management Pharmacogenetics (PGx) Gene Variation Panel
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Pain Management Pharmacogenetics (PGx) Gene Variation Panel
Medical Test

Reference Ranges
Access to Pain Management Pharmacogenetics (PGx) Gene Variation Panel is restricted.
Loading...